Erratum: Knockdown of HOXA10 reverses the multidrug resistance of human chronic mylogenous leukemia K562/ADM cells by downregulating P‑gp and MRP‑1 (Int JMol Med (2016) 37 (1405‑1411) DOI: 10.3892/ijmm.2016.2539);Knockdown of HOXA10 reverses the multidrug resistance of human chronic mylogenous leukemia K562/ADM cells by downregulating P-gp and MRP-1

International Journal of Molecular Medicine

Volumn 37, Issue 5, 2016, Pages 1405-1411

  Yi, Ying Jie ^a   Jia, Xiu Hong ^a   Wang, Jian Yong ^b   Li, You Jie ^a   Wang, Hong ^a   Xie, Shu Yang ^a  

^a BINZHOU MEDICAL UNIVERSITY   (China)

^b YANTAI YUHUANGDING HOSPITAL   (China)

Author keywords

Homeobox A10; Multidrug resistance; Multidrug resistance protein 1; P glycoprotein; Reverse; Short hairpin RNA

Indexed keywords

DOXORUBICIN; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR HOXA10; HOMEODOMAIN PROTEIN; HOXA10 PROTEIN, HUMAN; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1; SMALL INTERFERING RNA;

ARTICLE; CANCER RESISTANCE; CHRONIC MYELOID LEUKEMIA; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACCUMULATION; DRUG EFFICACY; DRUG SENSITIVITY; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; K562 CELL LINE; K562/ADM CELL LINE; LEUKEMIA CELL LINE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; K-562 CELL LINE; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; METABOLISM; RNA INTERFERENCE; TUMOR CELL LINE;

CELL LINE, TUMOR; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, LEUKEMIC; GENE KNOCKDOWN TECHNIQUES; HOMEODOMAIN PROTEINS; HUMANS; K562 CELLS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84963612267     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2023.5315     Document Type: Erratum

References (25)

1. Li H, Guo K, Wu C, Shu L, Guo S, Hou J, Zhao N, Wei L, Man X and Zhang L: Controlled and targeted drug delivery by a UV-responsive liposome for overcoming chemo-resistance in non-Hodgkin lymphoma. Chem Biol Drug 86: 783-794, 2015.
2. Nabekura T, Hiroi T, Kawasaki T and Uwai Y: Effects of natural nuclear factor-kappa B inhibitors on anticancer drug efflux transporter human P-glycoprotein. Biomed Pharmacother 70: 140-145, 2015
3. Ren J, Xu Y, Huang Q, Yang J, Yang M, Hu K and Wei K: Chab-amide induces cell cycle arrest and apoptosis by the Akt/MAPK pathway and inhibition of P-glycoprotein in K562/ADR cells. Anticancer Drugs 26: 498-507, 2015
4. Wen X, Zhang HD, Zhao L, Yao YF, Zhao JH and Tang JH: Ginsenoside Rh2 differentially mediates microRNA expression to prevent chemoresistance of breast cancer. Asian Pac J Cancer Prev 16: 1105-1109, 2015
5. Bao W, Zhu F, Duan Y, Yang Y and Cai H: HtrA1 resensitizes multidrug-resistant hepatocellular carcinoma cells by targeting XIAP. Biomed Pharmacother 70: 97-102, 2015
6. Wang Z, Yang L, Xia Y, Guo C and Kong L: Icariin enhances cytotoxicity of doxorubicin in human multidrug-resistant osteosarcoma cells by inhibition of ABCB1 and down-regulation of the PI3K/Akt pathway. Biol Pharm Bull 38: 277-284, 2015
7. Song YN, Guo XL, Zheng BB, Liu XY, Dong X, Yu LG and Cheng YN: Ligustrazine derivate DLJ14 reduces multidrug resistance of K562/A02 cells by modulating GSTπ activity. Toxicol In Vitro 25937-943, 2011.
8. Ma J, Wang T, Guo R, Yang X, Yin J, Yu J, Xiang Q, Pan X, Tang H and Lei X: Involvement of miR-133a and miR-326 in ADM resistance of HepG2 through modulating expression of ABCC1. J Drug Target 23: 519-524, 2015
9. Yang X, Iyer AK, Singh A, Choy E, Hornicek FJ, Amiji MM and Duan Z: MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer. Sci Rep 5: 8509, 2015
10. Fantappiè O, Sassoli C, Tani A, Nosi D, Marchetti S, Formigli L and Mazzanti R: Mitochondria of a human multidrug-resistant hepatocellular carcinoma cell line constitutively express inducible nitric oxide synthase in the inner membrane. J Cell Mol Med 19: 1410-1417, 2015
11. Xu X, Zhang Y, Li W, Miao H, Zhang H, Zhou Y, Li Z, You Q, Zhao L and Guo Q: Wogonin reverses multi-drug resistance of human myelogenous leukemia K562/A02 cells via downregu-lation of MRP1 expression by inhibiting Nrf2/ARE signaling pathway. Biochem Pharmacol 92: 220-234, 2014
12. Bei L, Shah C, Wang H, Huang W, Roy R and Eklund EA: β-catenin activates the HOXA10 and CDX4 genes in myeloid progenitor cells. J Biol Chem 287: 39589-39601, 2012.
13. Wang H, Lindsey S, Konieczna I, Bei L, Horvath E, Huang W, Saberwal G and Eklund EA: Constitutively active SHP2 cooperates with HoxA10 overexpression to induce acute myeloid leukemia. J Biol Chem 284: 2549-2567, 2009
14. Vitiello D, Pinard R and Taylor HS: Gene expression profling reveals putative HOXA10 downstream targets in the periimplan-tation mouse uterus. Reprod Sci 15: 529-535, 2008.
15. Bei L, Huang W, Wang H, Shah C, Horvath E and Eklund E: HoxA10 activates CDX4 transcription and Cdx4 activates HOXA10 transcription in myeloid cells. J Biol Chem 286: 19047-19064, 2011.
16. Magnusson M, Brun AC, Miyake N, Larsson J, Ehinger M, Bjornsson JM, Wutz A, Sigvardsson M and Karlsson S: HOXA10 is a critical regulator for hematopoietic stem cells and erythroid/megakaryocyte development. Blood 109: 3687-3696, 2007
17. Kim JW, Kim JY, Kim JE, Kim SK, Chung HT and Park CK: HOXA10 is associated with temozolomide resistance through regulation of the homologous recombinant DNA repair pathway in glioblastoma cell lines. Genes Cancer 5: 165-174, 2014
18. Gaspar N, Marshall L, Perryman L, Bax DA, Little SE, Viana-Pereira M, Sharp SY, Vassal G, Pearson AD, Reis RM, et al: MGMT-independent temozolomide resistance in pediatric glioblastoma cells associated with a PI3-kinase-mediated HOX/stem cell gene signature. Cancer Res 70: 9243-9252, 2010.
19. Wang JY, Jia XH, Xing HY, Li YJ, Fan WW, Li N and Xie SY: Inhibition of Forkhead box protein M1 by thiostrepton increases chemosensitivity to doxorubicin in T-cell acute lymphoblastic leukemia. Mol Med Rep 12: 1457-1464, 2015
20. Sengupta A, Banerjee D, Chandra S, Banerji SK, Ghosh R, Roy R and Banerjee S: Deregulation and cross talk among Sonic hedgehog, Wnt, Hox and Notch signaling in chronic myeloid leukemia progression. Leukemia 21: 949-955, 2007
21. Abdallah HM, Al-Abd AM, El-Dine RS and El-Halawany AM: P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: a review. J Adv Res 6: 45-62, 2015
22. Sloma I, Imren S, Beer PA, Zhao Y, Lecault V, Leung D, Ragh-uram K, Brimacombe C, Lambie K, Piret J, et al: Ex vivo expansion of normal and chronic myeloid leukemic stem cells without functional alteration using a NUP98HOXA10homeodomain fusion gene. Leukemia 27: 159-169, 2013.
23. Yao J, Fang LC, Yang ZL, Huang H, Li Y, Deng J and Zheng J: Mixed lineage leukaemia histone methylases 1 collaborate with ERα to regulate HOXA10 expression in AML. Biosci Rep 34: e00156, 2014
24. Zhang L, Wan Y, Jiang Y, Ma J, Liu J, Tang W, Wang X and Cheng W: Upregulation HOXA10 homeobox gene in endometrial cancer: role in cell cycle regulation. Med Oncol 31: 52, 2014
25. Wang XB, Wang SS, Zhang QF, Liu M, Li HL, Liu Y, Wang JN, Zheng F, Guo LY and Xiang JZ: Inhibition of tetramethylpyrazine on P-gp, MRP2, MRP3 and MRP5 in multidrug resistant human hepatocellular carcinoma cells. Oncol Rep 23: 211-215, 2010.